BD launches first-in-human trial of sirolimus drug-coated balloon
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) has announced the start of enrollment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). BD is a pioneer in DCB technology as the first to gain U.S. FDA approval for a paclitaxel DCB. BD’s Lutonix, which received FDA approval in 2014, is celebrating
